(Q40973646)

25 September 2017

DRUG-INDUCED IN-VITRO STIMULATION OF PERIPHERAL LYMPHOCYTES. (English)

1 reference

25 September 2017

P HOLLAND

1

1 reference

PubMed ID

14184152

25 September 2017

A M MAUER

series ordinal

2

1 reference

PubMed ID

14184152

25 September 2017

language of work or name

English

0 references

publication date

1 June 1964

1 reference

25 September 2017

1 reference

25 September 2017

1

1 reference

25 September 2017

1368-1369

1 reference

25 September 2017

7347

1 reference

DILANTIN-INDUCED SERUM SICKNESS. CASE REPORT AND INQUIRY INTO ITS MECHANISM

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2864%2992046-X

7 January 2021

Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2864%2992046-X

7 January 2021

DIAGNOSTICALLY CONFUSING COMPLICATIONS OF DIPHENYLHYDANTOIN THERAPY. A REVIEW.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2864%2992046-X

7 January 2021

DIPHENYLHYDANTOIN HYPERSENSITIVITY; TREATMENT WITH 6-MERCAPTOPURINE

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2864%2992046-X

7 January 2021

Tuberculin-induced mitosis in peripheral blood leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2864%2992046-X

7 January 2021

CHANGES INDUCED BY TUBERCULIN IN LEUCOCYTE CULTURES

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2864%2992046-X

7 January 2021

OCULAR LESIONS AFTER TREATMENT WITH CHLOROQUINE.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2864%2992046-X

7 January 2021

PIGMENTATION FROM ANTIMALARIAL THERAPY. ITS POSSIBLE RELATIONSHIP TO THE OCULAR LESIONS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2864%2992046-X

7 January 2021

Ocular abnormalities in patients treated with synthetic antimalarial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2864%2992046-X

7 January 2021

STUDIES ON THE PHARMACOLOGY OF CHLOROQUINE. RECOMMENDATIONS FOR THE TREATMENT OF CHLOROQUINE RETINOPATHY.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2864%2992046-X

7 January 2021

CHLOROQUINE. A REVIEW OF REACTIONS AND DERMATOLOGIC INDICATIONS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2864%2992046-X

7 January 2021

HISTOPATHOLOGY OF CHLOROQUINE RETINAL TOXICITY.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2864%2992046-X

7 January 2021

Anticipation of chloroquine retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2864%2992046-X

7 January 2021

Electrophysiological abnormalities in pigmentary degenerations of the retina. Assessment of value and basis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2864%2992046-X

7 January 2021

THE EOG IN CHLOROQUINE AND OTHER RETINOPATHIES.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2864%2992046-X

7 January 2021

10.1016/S0140-6736(64)92046-X

Identifiers

DOI

1 reference

25 September 2017

1 reference

PubMed ID

14184152